1. Home
  2. LYNX vs KARD Comparison

LYNX vs KARD Comparison

Compare LYNX & KARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lyntris Inc. Common Stock

LYNX

Lyntris Inc. Common Stock

N/A

Current Price

$12.10

Market Cap

1.3B

Sector

Industrials

ML Signal

N/A

Logo Kardigan Inc. Common Stock

KARD

Kardigan Inc. Common Stock

N/A

Current Price

$11.60

Market Cap

1.5B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
LYNX
KARD
Founded
2018
2023
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
2026
2026

Fundamental Metrics

Financial Performance
Metric
LYNX
KARD
Price
$12.10
$11.60
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
9
Target Price
$19.83
★ $41.00
AVG Volume (30 Days)
★ 520.3K
441.3K
Earning Date
11-04-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$61.71
N/A
Revenue Next Year
$30.33
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.75
$12.23
52 Week High
$15.50
$27.00

Technical Indicators

Market Signals
Indicator
LYNX
KARD
Relative Strength Index (RSI) 45.47 35.74
Support Level $10.49 N/A
Resistance Level $13.74 $16.26
Average True Range (ATR) 1.22 1.30
MACD -0.08 -0.24
Stochastic Oscillator 47.45 0.60

Price Performance

Historical Comparison
LYNX
KARD

About LYNX Lyntris Inc. Common Stock

Lyntris Inc is a defense technology company that develops connectivity solutions for military applications. Its products consist of interconnected subsystems designed to support defense and military customers in detecting threats, making decisions, and responding to operational requirements across multi-domain environments. The company serves U.S. and allied nation military customers. Its solutions are deployed across three core missions: Maritime Domain Awareness; Air & Missile Defense; and Space ISR & Resilient Communications. Maximum revenue is derived from the Maritime Domain Awareness business, which includes solutions focused on maritime monitoring, tracking and analysis that support government and defense customers in maintaining situational awareness across maritime environments.

About KARD Kardigan Inc. Common Stock

Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.

Share on Social Networks: